U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645235) titled 'A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women' on June 08.
Brief Summary: This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.
Study Start Date: July 09
Study Type: INTERVENTIONAL
Condition:
Urinary Tract Infections
Intervention:
DRUG: Gepotidacin
A single oral dose of 3000 mg gepotidacin will be administered
Recruitment Status: NOT_YET_RECRUITING
Sponsor: GlaxoSmithKline
Disclaimer: Curated by HT Syndication....